Wang Sainan, Niu Yuting, Jia Peipei, Liao Zheting, Guo Weimin, Chaves Rodrigo Cotrim, Tran-Ba Khanh-Hoa, He Ling, Bai Hanying, Sia Sam, Kaufman Laura J, Wang Xiaoyan, Zhou Yongsheng, Dong Yanmei, Mao Jeremy J
Department of Cariology and Endodontology, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Center for Craniofacial Regeneration, Columbia University, New York, NY, 10032, USA.
Bioact Mater. 2021 Dec 23;15:316-329. doi: 10.1016/j.bioactmat.2021.12.015. eCollection 2022 Sep.
Utilization of the body's regenerative potential for tissue repair is known as in situ tissue regeneration. However, the use of exogenous growth factors requires delicate control of the dose and delivery strategies and may be accompanied by safety, efficacy and cost concerns. In this study, we developed, for the first time, a biomaterial-based strategy to activate endogenous transforming growth factor beta 1 (TGFβ1) under alkaline conditions for effective in situ tissue regeneration. We demonstrated that alkaline-activated TGFβ1 from blood serum, bone marrow fluids and soaking solutions of meniscus and tooth dentin was capable of increasing cell recruitment and early differentiation, implying its broad practicability. Furthermore, we engineered an injectable hydrogel (MS-Gel) consisting of gelatin microspheres for loading strong alkaline substances and a modified gelatin matrix for hydrogel click crosslinking. In vitro models showed that alkaline MS-Gel controllably and sustainably activated endogenous TGFβ1 from tooth dentin for robust bone marrow stem cell migration More importantly, infusion of in vivo porcine prepared root canals with alkaline MS-Gel promoted significant pulp-dentin regeneration with neurovascular stroma and mineralized tissue by endogenous proliferative cells. Therefore, this work offers a new bench-to-beside translation strategy using biomaterial-activated endogenous biomolecules to achieve in situ tissue regeneration without the need for cell or protein delivery.
利用人体的再生潜能进行组织修复被称为原位组织再生。然而,外源性生长因子的使用需要精确控制剂量和递送策略,并且可能伴随着安全性、有效性和成本方面的问题。在本研究中,我们首次开发了一种基于生物材料的策略,在碱性条件下激活内源性转化生长因子β1(TGFβ1),以实现有效的原位组织再生。我们证明,来自血清、骨髓液以及半月板和牙本质浸泡液中的碱性激活TGFβ1能够增加细胞募集和早期分化,这意味着其具有广泛的实用性。此外,我们设计了一种可注射水凝胶(MS-Gel),它由用于负载强碱性物质的明胶微球和用于水凝胶点击交联的改性明胶基质组成。体外模型表明,碱性MS-Gel可控且持续地激活来自牙本质的内源性TGFβ1,以促进强大的骨髓干细胞迁移。更重要的是,用碱性MS-Gel灌注体内猪制备的根管,通过内源性增殖细胞促进了具有神经血管基质和矿化组织的显著牙髓-牙本质再生。因此,这项工作提供了一种新的从实验台到床边的转化策略,利用生物材料激活内源性生物分子来实现原位组织再生,而无需细胞或蛋白质递送。